While Congress moves closer to pharmacy benefit manager reform with new legislation pending, "achieving large reductions in prescription drug costs" will require a different approach, says the Brookings Institution.
As the U.S. struggles with the shortages, a group of Republican governors wrote a letter to Congressional leaders, citing shortfalls of critical meds like amoxicillin and called for added transparency in the pharmaceutical supply chain.
The Centers for Medicare & Medicaid Services sent a letter to Medicaid directors in all 50 states, requiring them to determine whether they have an eligibility systems issue that could cause children to be dis-enrolled from Medicaid.